Navigation Links
ShangPharma to Attend Two Upcoming Investor Conferences
Date:11/28/2011

SHANGHAI, Nov. 28, 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that it is scheduled to present at the following investor conferences in December 2011:

Ms. Lan Xie, Vice President of Finance and Investor Relations of ShangPharma, will present at the following conferences:

  • Deutsche Bank 5th Annual MedTools Investor Summit, December 5-6, 2011, Boston
  • Oppenheimer 22nd Annual Healthcare Conference, December 13-14, 2011, New York City

  • Presentation materials will be available under the Webcasts & Presentations section of the Company's investor relations website at http://ir.shangpharma.com.

    ABOUT SHANGPHARMA CORPORATIONShangPharma Corporation (NYSE: SHP) is a leading China-based contract research organization providing high quality and cost-effective services for the pharmaceutical and biotechnology industry. It offers a broad range of high-quality, integrated services across the drug discovery and development process to help international and Chinese pharmaceutical and biotechnology companies discover and develop novel drug candidates efficiently. ShangPharma's services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. For more information, please visit www.shangpharma.com.For further information, please contact:  ShangPharma Ms. Lan XieVP of Finance and Investor RelationsEmail: ir@shangpharma.comBrunswick GroupLilian WongEmail: shangpharma@brunswickgroup.com Phone: 86-10-5960-8600
    '/>"/>

    SOURCE ShangPharma Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. ShangPharma Announces Third Quarter 2011 Results
    2. ShangPharma Purchases Shanghai In-vivo Drug Research Facility from Charles River
    3. ShangPharma Corporation Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting
    4. ShangPharma Corporation Announces Resignation of a Director
    5. ShangPharma Corporation to Hold 2011 Annual General Meeting on October 14, 2011
    6. ShangPharma Announces Up to $10 Million Share Repurchase Program
    7. ShangPharmas Biologics Division Announces Accelerated Achievement of Milestones for Two Multi-Stage Projects
    8. ShangPharma Corporation to Announce First Quarter 2011 Financial Results on May 19, 2011
    9. ShangPharma Corporation Files 2010 Annual Report on Form 20-F
    10. ShangPharma Announces Fourth Quarter and Fiscal Year 2010 Results
    11. ShangPharma to Present at the Citibank Global Health Care Conference from March 1 - 3, 2011
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
    (Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
    (Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
    Breaking Medicine Technology:
    (Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
    (Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
    (Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
    (Date:6/24/2016)... , ... June 24, 2016 , ... ... is proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon ... beautiful women in the world, and the most handsome men, look naturally attractive. ...
    (Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners ... extensive sequencing and genomics experience, as Vice President of North American Capital Sales at ... responsible for leading the sales team in the commercialization of the HTG EdgeSeq system ...
    Breaking Medicine News(10 mins):